Genetic Testing for Glaucoma

Genetic testing to help determine #glaucoma risk? Say no more! 👁️ At the World Glaucoma Congress, Dr. Paul Singh talked with Howard Edwards of Seonix Bio to discuss groundbreaking advances in glaucoma care. They highlighted Seonix’s SightScore™ a first-in-class polygenic risk score (PRS) saliva test that analyzes millions of genetic variants to generate a personalized glaucoma risk profile. Unlike traditional risk assessments based on age, family history, eye pressure, or imaging #SightScore provides clinicians with a more powerful, genetically informed tool to: • Identify individuals at high genetic risk before symptoms appear • Gauge the likelihood of disease progression in diagnosed patients • Inform personalized screening schedules and treatment strategies • Flag low-risk individuals who may need less frequent monitoring Currently available to clinicians in the U.S., Australia, and New Zealand, SightScore is revolutionizing how eye‑care professionals triage and manage glaucoma. With genetic insight, practices can now intervene earlier, tailor follow-up frequency, and even guide when relatives should be screened #Genetictesting #eyecare #ophthalmology #optometry Disclosures: Seonix Bio